欣母沛预防前置胎盘剖宫产产后出血临床探讨.docVIP

欣母沛预防前置胎盘剖宫产产后出血临床探讨 　　[摘要]目的 探讨宫体肌壁注射欣母沛在预防前置胎盘剖宫产术后出血的疗效。方法 选取该院2012年4月―2014年3月拟行剖宫产终止妊娠的前置胎盘孕妇66例。将66例病例随机分为两组：对照组33例，给予常规治疗。研究组33例，常规治疗基础上给予欣母沛宫体肌壁注射。比较两组患者的治疗效果及出血量情况。结果 研究组总有效率：96.9 %，对照组总有效率78.8 %，研究组总有效率明显高于对照组；研究组术中、术后2h及术后24h出血量明显低于对照组。两组对比疗效差异有统计学意义（P0.05），有统计学意义。结论 欣母沛能有效促进子宫收缩，降低前置胎盘剖宫产术中及产后出血发生率，疗效显著，值得在临床推广。 　　[关键词]欣母沛；前置胎盘；剖宫产；疗效；出血 　　[中图分类号]R719.8 [文献标识码]A [文章编号]1674-0742（2015）03（c）-0117-02 　　[Abstract]Objective To observe the muscle wall of the Palace Hemabate injection in preventing placenta previa hemorrhage after cesarean section.Methods A hospital in April 2012―2014 March intends to terminate the pregnancy cesarean section 41 cases of pregnant women with placenta previa.The 41 cases were randomly divided into two groups： a control group of 19 patients treated with conventional therapy. 22 cases of the study group on the basis of conventional treatment given Hemabate Palace muscle wall injection. Therapeutic effects were compared in patients with and bleeding conditions.Results The total effective rate： 96.9% in the control group， the total efficiency of 78.8%，the study group was significantly higher than the total efficiency； study group postoperative 2 hours and after 24 hours the amount of bleeding was significantly lower than the control groups. Significant difference in efficacy between two groups （P 0.05）， there are statistically significant.Conclusion Hemabate can effectively promote uterine contractions and reduce placenta previa and postpartum hemorrhage in cesarean section rates， a significant effect， worthy of promotion. 　　[ Keywords] Hemabate；Placenta previa；Cesarean section； Efficacy；Bleeding 　　前置胎盘是妊娠晚期严重的并发症之一，在我国国内的发生率为0.24%～1.57%。近年来随着人工流产次数增加、剖宫产率持续攀升以及辅助生殖技术的广泛开展，前置胎盘发生率明显提高。前置胎盘主要表现为妊娠晚期无诱因、无痛性、反复阴道流血。前置胎盘妊娠末期胎儿娩出后由于子宫下段肌层组织菲薄，收缩力差，导致开放的血窦不易关闭，不论阴式分娩还是剖宫产都极易发生产后出血。尤其是剖宫产术中，若处理不及时或不当，易继发产时、产后大出血，出血量多且难以控制，往往有子宫切除可能，严重时会危及母儿生命安全[1]。该院在临床工作中对前置胎盘剖宫产术孕妇采用在常规治疗基础上给予欣母沛宫体肌壁注射，取得了非常好的治疗效果，现报道如下。 　　1 资料与方法 　　1.1 一般资料 　　选取20